Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients

Basit Öğe Kaydı
dc.authoridcengiz, ahmet kivanc/0000-0002-4390-7169
dc.authoridGuler, Tuba/0000-0002-7986-931X
dc.authoridcuzdan balta, nihan/0000-0001-7238-657X
dc.authoridketenci, sertac/0000-0002-2950-8778
dc.authoridDurmaz, Yunus/0000-0002-1727-0088
dc.contributor.authorYurdakul, Fatma
dc.contributor.authorBodur, Hatice
dc.contributor.authorCengiz, Ahmet Kivanc
dc.contributor.authorDurmaz, Yunus
dc.contributor.authorDuruoz, Mehmet Tuncay
dc.contributor.authorKaya, Taciser
dc.contributor.authorKetenci, Sertac
dc.date.accessioned2024-09-18T20:15:15Z
dc.date.available2024-09-18T20:15:15Z
dc.date.issued2024
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractObjectives: This study aimed to assess the clinical outcomes and risk factors for severe coronavirus disease 2019 (COVID-19) in patients with inflammatory rheumatic disease (IRD) of a national cohort. Patients and methods: The multicenter cross-sectional study was carried out between July 15, 2020, and February 28, 2021. Data collection was provided from a national network database system, and 3,532 IRD patients (2,359 males, 1,173 females; mean age: 48.7 +/- 13.9 years; range; 18 to 90 years) were analyzed. Demographics, clinics about rheumatic disease, comorbidities, smoking status, being infected with COVID-19, and the course of the infection were questioned by rheumatology specialists. Results: One hundred seventeen patients were infected with COVID-19, the hospitalization rate due to COVID-19 was 58.9%, and the mortality rate was 1.7%. There was no difference between the COVID-19 positive and negative groups in terms of rheumatic disease activities and receiving drugs. It was observed that patients with COVID-19 had worse compliance with isolation rules, and bacillus Calmette-Guerin (BCG) vaccination was less common. The mean age and the rate of smoking of hospitalized COVID-19 patients were higher than those without hospitalization. Conclusion: In this cohort, in which real-life data were analyzed, COVID-19 rates in IRD patients were similar to the general population for the same period. Compliance with the isolation rules and BCG vaccination attracted attention as components that reduce the risk of COVID-19 infection. The risk factors for hospitalization were older age and smoking.en_US
dc.identifier.doi10.46497/ArchRheumatol.2024.10313
dc.identifier.endpage212en_US
dc.identifier.issn2618-6500
dc.identifier.issue2en_US
dc.identifier.pmid38933732en_US
dc.identifier.scopus2-s2.0-85194162751en_US
dc.identifier.scopusquality#BAŞV!en_US
dc.identifier.startpage203en_US
dc.identifier.urihttps://doi.org/10.46497/ArchRheumatol.2024.10313
dc.identifier.urihttps://hdl.handle.net/20.500.12483/9533
dc.identifier.volume39en_US
dc.identifier.wosWOS:001189431000001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish League Against Rheumatismen_US
dc.relation.ispartofArchives of Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDisease-modifying antirheumatic drugsen_US
dc.subjecthospitalizationen_US
dc.subjectmortality rateen_US
dc.subjectrheumatic diseasesen_US
dc.subjectsevere acute respiratory syndrome coronavirus 2en_US
dc.titlePandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
255.3 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu